Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Charles Theuer Net Worth & Insider Trades

Charles Theuer - President and CEO, Tracon Pharmaceuticals, Inc

As of April 28, 2023

What is Charles Theuer's Net Worth?

The current estimated net worth of Tracon Pharmaceuticals, Inc's President and CEO, Charles Theuer, is estimated to be about $225.24K . Charles Theuer owns about 399,417 units of Tracon Pharmaceuticals, Inc common stock. In the last 8 years at Tracon Pharmaceuticals, Inc, Charles Theuer has sold an estimated value of $305.22K worth.

What is Charles Theuer's Past Insider Trading?

Charles Theuer's largest purchase order was 11,000 units , worth over $98.77K on January 28, 2021. Charles Theuer's largest sale order was 10,000 units , worth over $173.4K on September 22, 2015. In total, Charles Theuer has made about 52 transactions over 8 years of their time at Tracon Pharmaceuticals, Inc. Charles Theuer usually trades in January and August, with the busiest year in 2022. The most recent transaction was a purchase order of 50,999 units , worth over $37.89K on April 28, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CHARLES THEUER

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Charles Theuer's' Mailing Address?

  • Mailing address is C/o Tracon Pharmaceuticals, Inc. 8910 University Center Lane, Ste 700 San Diego CA 92122 CA

What are Tracon Pharmaceuticals, Inc's Past Insider Trades?

Tracon Pharmaceuticals, Inc's most recent insider trade came on November 14, 2023 by Opaleye Management Inc who sold 4,764,008 units worth $1.4M . In the last 8 years, insiders at Tracon Pharmaceuticals, Inc have sold an estimated value of $6.73M and bought an estimated value of $151.41M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Charles Theuer, President and CEO,  Opaleye Management Inc,  and Partnership Limited Investment Super Jafco V .

Tracon Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...